In the future as sales representatives become more “specialized” to meet physician demands for “scientific value”, the lines between the field-sales function and the field-medical science liaison function could become more blurred unless pharmaceutical companies proactively define the boundaries.
Defining the boundaries is a key first step, but it is never the only step. Most cross-functional break-down between field-medical science liaison teams and field-sales teams occur because both functions are not “on the same page” about where the “MSL-sales divide” must occur. Where there is an interaction, teams are often unclear about the rules of engagement governing the interaction when a medical science liaison and a sales representative are both present in front of a physician.
MSL Institute’s efforts in providing subject matter expertise and MSL compliance content to our strategic business partners aim to bring high quality, timely, and practical knowledge that your company’s medical science liaisons and sales representatives MUST KNOW in order to remain competitive and compliant.
Jane Chin, Ph.D. info@msliq.com
Founder, MSL Institute